The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

Evan Y. Yu, MD, discusses how safety data for first-line androgen deprivation therapy plus androgen receptor pathway inhibitors (ARPI) regimens such as darolutamide, abiraterone, enzalutamide, and ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, ...

Women are now being diagnosed with cancer more often than men in certain age groups, according to a new report from the ...

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

After increases over the past three years, the five-year relative survival rate for pancreatic cancer remains flat at 13%, ...

Princess Kate Middleton opened up about the side effects of chemo when she visited the Royal Marsden Hospital in London, ...

Cancer cases are shifting from men to women in the U.S., and from older to younger adults, according to a new report from the ...

Biomerica is reinforcing its commitment to expanding access to innovative diagnostic solutions in the Middle East. The company’s vision remains focused on providing affordable, accurate, and ...